Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
122.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.50 (2.066%)
Market Cap: £194.77m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Share Buyback Programme

17 Sep 2019 07:00

RNS Number : 5232M
Redcentric PLC
17 September 2019
Β 

17 September 2019

Redcentric plc

("Redcentric" or the "Company")

Β 

Β Share Buyback Programme

Β 

Redcentric plc (AIM: RCN) announces that it has approved a share buyback programme of ordinary shares of 0.1p in the capital of the Company ("Ordinary Shares") for an aggregate purchase price of up to Β£2 million (the "Buyback Programme"). The Buyback Programme forms part of the Group's broader strategy to deliver shareholder value.

Β 

The Buyback Programme will be independently managed by finnCap Ltd, the Company's joint broker, which will make trading decisions independently and without the influence of the Company.

Β 

The Buyback Programme is in accordance with the terms of the Company's authority to make market purchases of its own Ordinary Shares which was granted at the Company' Annual General Meeting on 2 September 2019 (the "Authority"). The maximum price paid per Ordinary Share is to be no more than 105 per cent. of the average middle market closing price of an Ordinary Share for the five business days preceding the date of purchase. The Buyback Programme will commence today and will continue until such time that the board of directors of the Company decides to end the Buyback Programme, at which point a further announcement will be made by the Company.

Β 

Any Ordinary Shares acquired as a result of the Buyback Programme will be held in treasury and be announced to the market without delay.

Β 

Due to the limited liquidity in the issued Ordinary Shares, any Buyback of Ordinary Shares pursuant to the Authority on any trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares on AIM and may exceed 25 per cent. of the average daily trading volume, being the limit laid down in Article 5(1) of Regulation (EU) No 596/2014 and, accordingly, the Company will not benefit from the exemption contained in this Article.

Β 

The Company confirms that it currently has no other unpublished price sensitive information other than what has been disclosed above.

Β 

Β Enquiries:

Β 

Redcentric plc

Β 

Peter Brotherton, Chief Executive Officer

Via Tulchan

Dean Barber, Chief Financial Officer

Β 

Β 

Β 

Tulchan

+44 (0)20 7353 4200

James Macey White / Matt Low

Β 

Β 

Β 

Numis Securities Limited - Nomad and Joint Broker

+44 (0)20 7260 1000

Simon Willis / Oliver Hardy

Β 

Β 

Β 

finnCap Ltd - Joint Broker

+44 (0)20 7220 0500

Stuart Andrews / Rhys Williams

Β 

Β 

Β 

Β 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
POSFMGMLLVVGLZM
Date   Source Headline
6th Dec 201311:59 amRNSHolding(s) in Company
5th Dec 201311:23 amRNSHolding(s) in Company
5th Dec 201311:05 amRNSResult of general meeting and re-admission to AIM
21st Nov 20136:12 pmRNSHolding(s) in Company
20th Nov 20135:46 pmRNSHolding(s) in Company
20th Nov 20134:49 pmRNSHolding(s) in Company
19th Nov 20133:50 pmRNSHolding(s) in Company
18th Nov 20131:00 pmRNSSchedule 1 - Redcentric plc
18th Nov 20137:00 amRNSAcquisition of InTechnology, Placing, Re Admission
28th Oct 20137:00 amRNSContract Wins
21st Oct 20137:00 amRNSContract Wins
30th Sep 20137:00 amRNSSupplementary Disclosure
17th Sep 20137:00 amRNSChange of Nominated Adviser
9th Sep 20132:20 pmRNSHolding(s) in Company
5th Jul 20139:25 amRNSHolding(s) in Company
5th Jul 20139:19 amRNSHolding(s) in Company
28th Jun 20137:01 amRNSDirectorate Change
28th Jun 20137:00 amRNSTrading Statement
27th Jun 20137:00 amRNSContract Wins
24th Jun 20137:00 amRNSIssue of Equity
21st May 20137:00 amRNSContract Wins
20th May 201312:17 pmRNSHolding(s) in Company
9th May 20137:00 amRNSContract Win
3rd May 201310:44 amRNSHolding(s) in Company
30th Apr 201310:17 amRNSHolding(s) in Company
30th Apr 201310:13 amRNSHolding(s) in Company
24th Apr 20137:00 amRNSFirst Day of Dealings and Admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.